PATENT CLAIM ANALYSIS

Application Number: 16297115
Application Type: Utility
Filing Date: 2019-03
Publication Date: 2019-07
Patent Classification: ["514", "210000"]

Abstract:
Indazole sulfonamide derivatives of formula (I), the pharmaceutically acceptable addition salts thereof, the hydrates and/or solvates thereof, and the use of same as inverse agonists of retinoid-related orphan receptor gamma RORγt are described. Pharmaceutical compositions including such compounds, as well as the use thereof for the topical and/or oral treatment of RORγt receptor-mediated inflammatory diseases, in particular acne, psoriasis and/or atopic dermatitis are also described.

Claim (Index 6):
The compound of formula (I) as defined by  claim 1 , wherein the compound is selected from the group consisting of:

Metadata:
- Claim Count in Document: 23.0
- Percentile: 99.0
- Lexical Diversity: 1.44231
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15537678', '15537580', '15537667', '15537591', '11029064']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8510977947712121
- 35 USC 102 Novelty (BERT): 0.6033174754479045
- Combined Prediction Score: 0.8263197628388813
- Mean Citation Score: 456.877754
- Max Citation Score: 546.8221
- Similarity Product: 486.9533962540984

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test